Physician

Anil Patel, M.D.

According to 2025 Medicare claims, Anil Patel, M.D. (NPI: 1396034369) practices allergy/immunology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is ALLERGY ASTHMA & ARTHRITIS ASSOCIATES P C (NPI: 1952364739; TIN: 232916058) and primary practice location at 18901-2511.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 359 traditional Medicare patients, billed 8,852 HCPCS/CPT codes, and received $107,031 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,747 prescription claims across 353 beneficiaries totaling $406,222 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). 2022 DME data shows 12 claims. Open Payments data shows 114 records totaling $2,425. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,776 to $107,031. Similarly, Part D prescription costs have moved sharply higher in recent years, from $5,341 to $406,222. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	73	402	$5,776
2017	145	3,189	$38,372
2018	149	3,031	$36,097
2019	172	3,596	$40,443
2020	201	3,745	$51,421
2021	263	4,526	$72,296
2022	274	7,118	$99,193
2023	303	6,941	$91,511
2024	359	8,852	$107,031

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	21	49	$5,341
2016	14	22	$2,809
2017	65	204	$26,238
2018	76	332	$36,753
2019	97	316	$47,076
2020	149	480	$87,911
2021	221	1,049	$228,815
2022	250	1,365	$297,580
2023	277	1,281	$239,293
2024	353	1,747	$406,222

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	12	$40
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	65	77	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	267	446	$62
94010	Test to measure expiratory airflow and volume	130	190	$19
95165	Professional service for preparation and provision of 1 or more antigens	104	2,485	$10
95117	Professional service for multiple injections of allergen	83	1,148	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	54	2,520	$52,378
Breo Ellipta	Fluticasone/Vilanterol	80	3,960	$49,638
Dupixent Pen	Dupilumab	12	336	$49,355
Xolair	Omalizumab	11	476	$49,083
Arnuity Ellipta	Fluticasone Furoate	76	3,840	$27,606

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	114	$2,425	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anil Patel, M.D.?

Tedicare shows public-source Medicare data for Anil Patel, M.D. (NPI 1396034369), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anil Patel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anil Patel, M.D.?

Anil Patel, M.D. is linked to ALLERGY ASTHMA & ARTHRITIS ASSOCIATES P C (billing NPI 1952364739) in the available physician profile data.

Does Anil Patel, M.D. have Open Payments data?

Anil Patel, M.D. has 114 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.